BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 20643235)

  • 1. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA; Edwards JR; Martin TJ; Mundy GR
    Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast cancer induces an osteoblast inflammatory response.
    Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
    Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.
    Lynch CC
    Bone; 2011 Jan; 48(1):44-53. PubMed ID: 20601294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Käkönen SM; Mundy GR
    Cancer; 2003 Feb; 97(3 Suppl):834-9. PubMed ID: 12548583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
    J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer metastasis to bone: it is not all about PTHrP.
    Bendre M; Gaddy D; Nicholas RW; Suva LJ
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S39-45. PubMed ID: 14600591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of stromal-derived cytokines and growth factors in bone metastasis.
    David Roodman G
    Cancer; 2003 Feb; 97(3 Suppl):733-8. PubMed ID: 12548570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
    Morgan H; Tumber A; Hill PA
    Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
    Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
    Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
    J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment.
    Sato S; Futakuchi M; Ogawa K; Asamoto M; Nakao K; Asai K; Shirai T
    Cancer Sci; 2008 Feb; 99(2):316-23. PubMed ID: 18271931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bone microenvironment in metastasis; what is special about bone?
    Bussard KM; Gay CV; Mastro AM
    Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms of bone resorption in breast carcinoma.
    Hunt NC; Fujikawa Y; Sabokbar A; Itonaga I; Harris A; Athanasou NA
    Br J Cancer; 2001 Jul; 85(1):78-84. PubMed ID: 11437406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal cells promote bone invasion by suppressing bone formation in ameloblastoma.
    Sathi GS; Nagatsuka H; Tamamura R; Fujii M; Gunduz M; Inoue M; Rivera RS; Nagai N
    Histopathology; 2008 Oct; 53(4):458-67. PubMed ID: 18983611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
    Yoneda T; Hiraga T
    Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.